跳至主要内容
临床试验/CTRI/2024/06/069213
CTRI/2024/06/069213尚未招募Unknown

ate Mortality, Burden of Morbidity and Quality of Life in Long Term Survivors of Hematopoietic Cell Transplantation: Experience from A Single Centre in India - NI

Advanced Centre for Treatment Research and Education in Cancer)0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients who underwent transplant autologous or allogeneic at ACTREC between 1st July 2007 and 30th June 2013
  • -Malignant hematological disorders and aplastic anemia
  • -Survived for more than 2 years with or without relapse of underlying disease
  • -Willing to provide an informed consent

排除标准

  • Multiple myeloma

研究者

发起方
Advanced Centre for Treatment Research and Education in Cancer)

相似试验

A prospective observational study to assess the... | 临床试验